CERT
Certara, Inc.
$5.22
-2.79%
$805.8M
No data for this timeframe.
Vol
Market Cap$805.8M
Cap SizeSmall Cap
Analyst ConsensusBuy (55%)
Inst. Holders8 funds
Inst. Value$163.8M
Inst. Activity1 buys / 5 sells
Reddit Sentiment33° Cool
SEC Reports6
Press Releases1
Recent Activity
Jun 1, 2026
Insider
Anhalt Rona sold 7,147 shares
Chief Human Resources Officer @ $0.00 ($0.00)
Jun 1, 2026
Insider
Anhalt Rona sold 7,147 shares
Chief Human Resources Officer @ $0.00 ($0.00)
Jun 1, 2026
Insider
Corcoran Daniel sold 4,210 shares
SVP and General Counsel @ $5.82 ($24.5K)
May 18, 2026
other
Certara to Participate in Upcoming Investor Conferences
<p>RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in
May 11, 2026
SEC
Certara reported Q1 2026 revenue of $106.9M (+1% YoY), but GAAP net loss widened to $8.8M from +$4.7M and adjusted dilut
8-K — Impact 6/10
May 11, 2026
SEC
Certara reported Q1 2026 adjusted diluted EPS of $0.09, missing the $0.11 consensus by 15.1%, while revenue of $106.9M w
PRESS-RELEASE — Impact 7/10
Apr 22, 2026
SEC
Certara agreed to sell its regulatory and medical writing business to Veristat for up to $135 million in cash, consistin
8-K, PRESS-RELEASE — Impact 7/10
Inst.
MORGAN STANLEY — ADD
5,055,818 shares ($44.5M)
Price Targets
$7.62
+47.1% upside
Strong Buy
Current $5.18
Low $6.00
Median $8.00
High $10.00
11 analysts
$6.00
$10.00
Analyst Ratings
4Strong Buy
7Buy
9Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 12, 2026 | Craig-Hallum | MAINTAIN | Hold → Hold |
| May 12, 2026 | BMO Capital | MAINTAIN | Market Perform → Market Perform |
| May 12, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
| May 12, 2026 | Stephens & Co. | MAINTAIN | Overweight → Overweight |
| May 12, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.09 ▼ -13.9% | $0.08 — $0.11 | 33% YoY | 9 |
| Next Q | $0.10 ▼ -12.9% | $0.09 — $0.11 | -29% YoY | 9 |
| Current FY | $0.38 ▼ -15.0% | $0.36 — $0.41 | -13% YoY | 12 |
| Next FY | $0.41 ▼ -17.1% | $0.33 — $0.46 | 8% YoY | 12 |
Latest Reports
BEARISH
8-K
6/10
Certara reported Q1 2026 revenue of $106.9M (+1% YoY), but GAAP net loss widened to $8.8M from +$4.7M and adjusted dilut
May 11, 2026
BEARISH
PRESS-RELEASE
7/10
Certara reported Q1 2026 adjusted diluted EPS of $0.09, missing the $0.11 consensus by 15.1%, while revenue of $106.9M w
May 11, 2026
BULLISH
Press
8/10
Certara announced that its Simcyp® Simulator was used to support the FDA's acceptance of PBPK modeling in lieu of clinic
Mar 3, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $105.0M | — |
| MORGAN STANLEY | $44.5M | ADD |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $7.4M | NEW |
| BANK OF AMERICA CORP | $4.6M | TRIM |
| TWO SIGMA INVESTMENTS, LP | $1.9M | TRIM |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 1, 2026 | Anhalt Rona | M | $0.00 |
| Jun 1, 2026 | Anhalt Rona | M | $0.00 |
| Jun 1, 2026 | Corcoran Daniel | F | $24.5K |
| Jun 1, 2026 | Corcoran Daniel | M | $0.00 |
| Jun 1, 2026 | Anhalt Rona | F | $13.0K |
Reddit Sentiment
33°
Cool
Bearish
Neutral
Bullish
8 institutional holders with $163.8M total value (18,595,364 shares) as of 2025-Q4. Top holders: VANGUARD, MORGAN, CHARLES. Net selling activity: 5 institutions trimmed/exited vs 1 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 11,916,099 | $105.0M | 64.1% | — |
| 2 | MORGAN STANLEY | 5,055,818 | $44.5M | 27.2% | ADD +59.3% |
| 3 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 843,796 | $7.4M | 4.5% | NEW |
| 4 | BANK OF AMERICA CORP /DE/ | 520,912 | $4.6M | 2.8% | TRIM -25.7% |
| 5 | TWO SIGMA INVESTMENTS, LP | 220,587 | $1.9M | 1.2% | TRIM -50.0% |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 29,600 | $260.8K | 0.2% | NEAR_EXIT -75.9% |
| 7 | FMR LLC | 5,556 | $48.9K | 0.0% | NEAR_EXIT -98.0% |
| 8 | WELLS FARGO & COMPANY/MN | 2,996 | $26.4K | 0.0% | TRIM -39.6% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | ADD | 3,173,682 | 5,055,818 | +59.3% | $44.5M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 701,473 | 520,912 | -25.7% | $4.6M | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 440,981 | 220,587 | -50.0% | $1.9M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | NEAR_EXIT | 122,620 | 29,600 | -75.9% | $260.8K | 2025-Q4 |
| FMR LLC | NEAR_EXIT | 284,172 | 5,556 | -98.0% | $48.9K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | TRIM | 4,964 | 2,996 | -39.6% | $26.4K | 2025-Q4 |
| UBS Group AG | DOUBLED | 800,706 | 1,651,955 | +106.3% | $20.2M | 2025-Q3 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 296,800 | 122,620 | -58.7% | $1.5M | 2025-Q3 |
| NORGES BANK | EXIT | 36,303 | 0 | -100.0% | $0.00 | 2025-Q3 |
| UBS Group AG | ADD | 469,276 | 800,706 | +70.6% | $9.4M | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 1,098,824 | 766,595 | -30.2% | $9.0M | 2025-Q2 |
| TWO SIGMA INVESTMENTS, LP | ADD | 200,447 | 379,247 | +89.2% | $4.4M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 296,800 | — | $3.5M | 2025-Q2 |
| NORGES BANK | NEW | — | 36,303 | — | $424.7K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | ADD | 2,495 | 4,903 | +96.5% | $57.4K | 2025-Q2 |
| MORGAN STANLEY | ADD | 1,356,655 | 2,575,960 | +89.9% | $25.5M | 2025-Q1 |
| CITADEL ADVISORS LLC | TRIM | 1,623,707 | 534,834 | -67.1% | $5.3M | 2025-Q1 |
| TWO SIGMA INVESTMENTS, LP | TRIM | 377,524 | 200,447 | -46.9% | $2.0M | 2025-Q1 |
| NORGES BANK | EXIT | 275,322 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 340,267 | 1,623,707 | +377.2% | $17.3M | 2024-Q4 |
| UBS Group AG | DOUBLED | 86,231 | 470,222 | +445.3% | $5.0M | 2024-Q4 |
| NORGES BANK | TRIM | 375,492 | 275,322 | -26.7% | $2.9M | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 2,161 | 3,208 | +48.4% | $34.2K | 2024-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | EXIT | 113,500 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 699,575 | — | $8.2M | 2024-Q3 |
14 unique insiders with 0 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Anhalt Rona | Chief Human Resources Officer | M | 7,147 | $0.00 | $0.00 |
| Jun 1, 2026 | Anhalt Rona | Chief Human Resources Officer | M | 7,147 | $0.00 | $0.00 |
| Jun 1, 2026 | Corcoran Daniel | SVP and General Counsel | F | 4,210 | $5.82 | $24.5K |
| Jun 1, 2026 | Corcoran Daniel | SVP and General Counsel | M | 7,941 | $0.00 | $0.00 |
| Jun 1, 2026 | Anhalt Rona | Chief Human Resources Officer | F | 2,241 | $5.82 | $13.0K |
| Jun 1, 2026 | Corcoran Daniel | SVP and General Counsel | M | 7,941 | $0.00 | $0.00 |
| May 14, 2026 | WALSH MATTHEW M | Director | A | 33,222 | $0.00 | $0.00 |
| May 14, 2026 | Crane Rosemary A | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | WALSH MATTHEW M | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | WALSH MATTHEW M | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Crane Rosemary A | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Killefer Nancy | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Killefer Nancy | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Killefer Nancy | Director | A | 33,222 | $0.00 | $0.00 |
| May 14, 2026 | BROSHY ERAN | Director | A | 33,222 | $0.00 | $0.00 |
| May 14, 2026 | Bedi Arjun | Director | M | 5,547 | $0.00 | $0.00 |
| May 14, 2026 | Bedi Arjun | Director | M | 5,547 | $0.00 | $0.00 |
| May 14, 2026 | Bedi Arjun | Director | A | 33,222 | $0.00 | $0.00 |
| May 14, 2026 | CASHMAN JAMES E III | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | CASHMAN JAMES E III | Director | A | 33,222 | $0.00 | $0.00 |
| May 14, 2026 | CASHMAN JAMES E III | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | BROSHY ERAN | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | BROSHY ERAN | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Reynders John V W | Chief Financial Officer | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Reynders John V W | Chief Financial Officer | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Reynders John V W | Chief Financial Officer | A | 33,222 | $0.00 | $0.00 |
| May 14, 2026 | Collins Cynthia | Director | M | 15,757 | $0.00 | $0.00 |
| May 14, 2026 | Collins Cynthia | Director | M | 15,757 | $0.00 | $0.00 |
| May 11, 2026 | Gallagher John E | Chief Financial Officer | D | 102,522 | $0.00 | $0.00 |
| May 11, 2026 | Gallagher John E | Chief Financial Officer | A | 102,522 | $0.00 | $0.00 |
| May 11, 2026 | Gallagher John E | Chief Financial Officer | A | 129,629 | $0.00 | $0.00 |
| May 11, 2026 | Resnick Jon Matthew | Chief Executive Officer | F | 24,377 | $6.31 | $153.8K |
| May 11, 2026 | Corcoran Daniel | SVP and General Counsel | D | 48,820 | $0.00 | $0.00 |
| May 11, 2026 | Corcoran Daniel | SVP and General Counsel | A | 48,820 | $0.00 | $0.00 |
| May 11, 2026 | Corcoran Daniel | SVP and General Counsel | A | 74,074 | $0.00 | $0.00 |
| May 11, 2026 | Resnick Jon Matthew | Chief Executive Officer | M | 59,766 | $0.00 | $0.00 |
| May 11, 2026 | Resnick Jon Matthew | Chief Executive Officer | A | 268,949 | $0.00 | $0.00 |
| May 11, 2026 | Resnick Jon Matthew | Chief Executive Officer | A | 179,299 | $0.00 | $0.00 |
| May 11, 2026 | Resnick Jon Matthew | Chief Executive Officer | M | 59,766 | $0.00 | $0.00 |
| May 11, 2026 | Anhalt Rona | Chief Human Resources Officer | D | 43,938 | $0.00 | $0.00 |
| May 11, 2026 | Anhalt Rona | Chief Human Resources Officer | A | 43,938 | $0.00 | $0.00 |
| May 11, 2026 | Anhalt Rona | Chief Human Resources Officer | A | 61,728 | $0.00 | $0.00 |
| May 11, 2026 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | D | 68,348 | $0.00 | $0.00 |
| May 11, 2026 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | A | 68,348 | $0.00 | $0.00 |
| May 11, 2026 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | A | 74,074 | $0.00 | $0.00 |
| May 11, 2026 | Aspbury Robert | PRESIDENT, PREDICTIVE TECH | D | 68,348 | $0.00 | $0.00 |
| May 11, 2026 | Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A | 68,348 | $0.00 | $0.00 |
| May 11, 2026 | Aspbury Robert | PRESIDENT, PREDICTIVE TECH | A | 86,419 | $0.00 | $0.00 |
| Apr 1, 2026 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | F | 3,534 | $5.70 | $20.1K |
| Apr 1, 2026 | Pedersen Leif E | PRESIDENT, CHIEF COMMERCAL OFF | M | 7,852 | $0.00 | $0.00 |
6 SEC filing reports analyzed. Sentiment: 1 bullish, 2 bearish, 1 mixed, 2 neutral. Avg impact: 5.5/10.
BEARISH
8-K
6/10
Certara reported Q1 2026 revenue of $106.9M (+1% YoY), but GAAP net loss widened to $8.8M from +$4.7
May 11, 2026
BEARISH
PRESS-RELEASE
7/10
Certara reported Q1 2026 adjusted diluted EPS of $0.09, missing the $0.11 consensus by 15.1%, while
May 11, 2026
BULLISH
8-K, PRESS-RELEASE
7/10
Certara agreed to sell its regulatory and medical writing business to Veristat for up to $135 millio
Apr 22, 2026
NEUTRAL
DEFA14A
4/10
Certara is holding its 2026 annual meeting to elect three Class III directors, ratify its auditor (R
Apr 3, 2026
NEUTRAL
COURT-RULING
3/10
Analysis based on filing metadata only — document content was unavailable
Mar 30, 2026
MIXED
8-K
6/10
Certara reported Q4 2025 revenue of $103.6M (3% YoY growth) and full-year revenue of $418.8M (9% gro
Feb 26, 2026
Current analyst consensus: Hold (55% buy). Based on 20 analysts: 4 strong buy, 7 buy, 9 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$7.62 mean target
+47.1% upside
Strong Buy (2.17)
$6.00 Low
$10.00 High
| Metric | Value |
|---|---|
| Current Price | $5.18 |
| Target Low | $6.00 |
| Target Mean | $7.62 |
| Target Median | $8.00 |
| Target High | $10.00 |
| # Analysts | 11 |
| Recommendation | Strong Buy (2.17) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.09 | $0.08 | $0.11 | 33.0% | -13.9% | 0↑ 10↓ | $0.1B | -4.9% | 9 |
| Next Q 2026-09-30 |
$0.10 | $0.09 | $0.11 | -28.9% | -12.9% | 0↑ 10↓ | $0.1B | -7.5% | 9 |
| Current FY 2026-12-31 |
$0.38 | $0.36 | $0.41 | -13.0% | -15.0% | 0↑ 12↓ | $0.4B | -4.9% | 12 |
| Next FY 2027-12-31 |
$0.41 | $0.33 | $0.46 | 8.0% | -17.1% | 0↑ 12↓ | $0.4B | 1.8% | 12 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.093 | |
| 7d ago | $0.108 | -0.015 |
| 30d ago | $0.108 | -0.015 |
| 60d ago | $0.108 | -0.015 |
| 90d ago | $0.130 | -0.037 |
8 analyst firms have rated this stock: 1 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 12, 2026 | Craig-Hallum | MAINTAIN | Hold | Hold |
| May 12, 2026 | BMO Capital | MAINTAIN | Market Perform | Market Perform |
| May 12, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 12, 2026 | Stephens & Co. | MAINTAIN | Overweight | Overweight |
| May 12, 2026 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| May 12, 2026 | Baird | MAINTAIN | Neutral | Neutral |
| Apr 13, 2026 | Keybanc | MAINTAIN | Overweight | Overweight |
| Mar 6, 2026 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
| Feb 27, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 8, 2026 | Keybanc | MAINTAIN | Overweight | Overweight |
| Jan 6, 2026 | Leerink Partners | UPGRADE | Market Perform | Outperform |
| Dec 18, 2025 | Morgan Stanley | MAINTAIN | Equal-Weight | Equal-Weight |
| Dec 15, 2025 | Barclays | MAINTAIN | Overweight | Overweight |
| Dec 12, 2025 | Stephens & Co. | MAINTAIN | Overweight | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 7 | 9 | 0 | 0 | 55% | |
| May 1, 2026 | 4 | 7 | 9 | 0 | 0 | 55% | |
| Apr 1, 2026 | 4 | 8 | 8 | 0 | 0 | 60% | |
| Mar 1, 2026 | 4 | 8 | 8 | 0 | 0 | 60% | |
| Feb 1, 2026 | 4 | 9 | 7 | 0 | 0 | 65% | |
| Jan 1, 2026 | 3 | 9 | 8 | 0 | 0 | 60% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
33°
Cool
Bearish
Neutral
Bullish
2 mentions
0 bullish
2 bearish
2 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 2, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 2, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
May 18, 2026
other
Certara to Participate in Upcoming Investor Conferences
<p>RADNOR, Pa., May 18, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced t
May 18, 2026
dark_pool
Dark Pool: CERT — 4.1M shares, 47,885 trades
Week starting 2026-05-18. Total ATS volume: 4,076,256 shares across 47,885 trades.
May 11, 2026
earnings
Certara Reports First Quarter 2026 Financial Results
Updates 2026 Guidance to reflect completed divestiture of Regulatory Writing and Medical Writing Business <pre>Updates 2026 Guidance to reflect comple
May 11, 2026
earnings_calendar
CERT Q1 2026 Earnings After Market Close — 2026-05-11
May 11, 2026
dark_pool
Dark Pool: CERT — 5.4M shares, 61,483 trades
Week starting 2026-05-11. Total ATS volume: 5,358,581 shares across 61,483 trades.
May 4, 2026
dark_pool
Dark Pool: CERT — 2.7M shares, 36,641 trades
Week starting 2026-05-04. Total ATS volume: 2,663,611 shares across 36,641 trades.
Apr 30, 2026
short_volume
Short Volume: CERT — 62.2% short (0.5M / 0.9M)
Short: 530,398 | Exempt: 0 | TRF Vol: 853,131 | Short Ratio: 62.2% | Off-exchange volume (dark pool + OTC)
Apr 27, 2026
dark_pool
Dark Pool: CERT — 2.5M shares, 39,072 trades
Week starting 2026-04-27. Total ATS volume: 2,451,625 shares across 39,072 trades.
Apr 22, 2026
contract
Certara Enters Definitive Agreement for the Sale of its Regulatory and Medical Writing Business to Veristat
<p align="center"><em>Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence </em></p>
Apr 22, 2026
short_volume
Short Volume: CERT — 60.6% short (0.6M / 1.0M)
Short: 624,203 | Exempt: 0 | TRF Vol: 1,029,685 | Short Ratio: 60.6% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
dark_pool
Dark Pool: CERT — 2.4M shares, 29,098 trades
Week starting 2026-04-20. Total ATS volume: 2,441,866 shares across 29,098 trades.
Apr 13, 2026
dark_pool
Dark Pool: CERT — 2.9M shares, 35,726 trades
Week starting 2026-04-13. Total ATS volume: 2,928,691 shares across 35,726 trades.
Apr 9, 2026
earnings
Certara to Report First Quarter 2026 Financial Results on May 11th, 2026
<p>RADNOR, Pa., April 09, 2026 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced
Apr 6, 2026
dark_pool
Dark Pool: CERT — 4.3M shares, 41,739 trades
Week starting 2026-04-06. Total ATS volume: 4,275,193 shares across 41,739 trades.
Apr 1, 2026
short_interest
FTD: CERT — 2,447,394 shares ($14.0M) failed to deliver
Settlement: 20260401, Price: $5.70, FTD Value: $13,950,145.8, CERTARA INC COM